rewirebio.iobenchmarks
Configuration

Lancet 1.1.0 (Guille et al. 2025)

Lancet as run in the cited comparison.

2 evaluations · 12 results

Overview

Lancet as run in the cited comparison.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

2 evaluations · 12 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.463 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), H31; Tools 'Lancet'; column 'F1'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
73 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), E31; Tools 'Lancet'; column 'FP'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
4.85e-7 false-positive-rate
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), G31; Tools 'Lancet'; column 'FPR'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.336 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), I31; Tools 'Lancet'; column 'PPV'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.74 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), F31; Tools 'Lancet'; column 'TPR'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic indels (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
37 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation indels (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-indel

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), D31; Tools 'Lancet'; column 'TP'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.659 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), H14; Tools 'Lancet'; column 'F1'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
653 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), E14; Tools 'Lancet'; column 'FP'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.00000434 false-positive-rate
fraction · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), G14; Tools 'Lancet'; column 'FPR'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.577 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), I14; Tools 'Lancet'; column 'PPV'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
0.767 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), F14; Tools 'Lancet'; column 'TPR'
Configuration: Lancet 1.1.0 (Guille et al. 2025)Protocol: SEQC2 HCC1395 WES validation sample, somatic SNVs (Guille et al. 2025 Table S7)
Dataset: SEQC2 HCC1395/HCC1395BL WES, Fudan replicate (WES_FD_T_1), high-confidence regions
890 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Lancet on SEQC2 HCC1395 WES validation SNVs (Guille et al. 2025)

somatic-20261009-protocol-guille2025-seqc2-fd-wes-snv

Aggregation: Not reported

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing; Guille et al. 2025, Supplementary Table S7 (validation dataset) · Supplementary Table S7 (tables7_bbae697.xls, sheet 'Results'), D14; Tools 'Lancet'; column 'TP'

Source checking is not independent reproduction. Release 2026-10-09-ba02f2f4a36e.

Use this model

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-09-ba02f2f4a36e
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-09-ba02f2f4a36e · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-20261009-config-guille2025-lancet

areas
dna-genomes
contexts
clinical_research
method types
conventional_pipeline
reported name
Lancet
version
1.1.0
protocol
Paired tumour-normal WES calling restricted to target regions; command line and parameters in the supplementary methods (section '#Lancet')
foundation model eligible
false
source locator
Table 1 row 'Lancet'; Supplementary Table S7 row label 'Lancet'; supplementary methods
Related records

Suggest a correction